Detalhe da pesquisa
1.
Association of Early Nasopharyngeal Immune Markers With COVID-19 Clinical Outcome: Predictive Value of CCL2/MCP-1.
Open Forum Infect Dis
; 7(10): ofaa407, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123608
2.
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Clin Transl Immunology
; 9(11): e1218, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33304584